Granahan Investment Management - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 28 filers reported holding CANCER GENETICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2018$66,000
-77.2%
272,818
-2.0%
0.01%
-68.8%
Q3 2018$289,000
+17.5%
278,260
+0.7%
0.02%
+6.7%
Q2 2018$246,000
-36.8%
276,417
+17.4%
0.02%
-46.4%
Q1 2018$389,000
-17.4%
235,502
-7.5%
0.03%
-24.3%
Q4 2017$471,000
-26.5%
254,461
+7.2%
0.04%
-30.2%
Q3 2017$641,000
-13.7%
237,431
+26.3%
0.05%
-22.1%
Q2 2017$743,000188,0600.07%
Other shareholders
CANCER GENETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 806,700$2,178,0002.28%
Fairbanks Capital Management, Inc. 233,170$629,0000.61%
THOMPSON DAVIS & CO., INC. 46,975$127,0000.22%
DIKER MANAGEMENT LLC 67,055$181,0000.07%
Granahan Investment Management 237,431$641,0000.05%
HRT FINANCIAL LP 15,301$41,0000.05%
WEDBUSH SECURITIES INC 47,800$129,0000.02%
TWO SIGMA SECURITIES, LLC 14,616$39,0000.00%
Virtu Financial LLC 18,600$50,0000.00%
Renaissance Technologies 569,400$1,537,0000.00%
View complete list of CANCER GENETICS INC shareholders